Anti-inflammatory activity of H1-receptor antagonists: review of recent experimental research

@article{Gelfand2004AntiinflammatoryAO,
  title={Anti-inflammatory activity of H1-receptor antagonists: review of recent experimental research},
  author={Erwin W Gelfand and Sireesh Appajosyula and Suzanne G Meeves},
  journal={Current Medical Research and Opinion},
  year={2004},
  volume={20},
  pages={73 - 81}
}
SUMMARY Objective: To compare the anti-inflammatory effects of fexofenadine with other H -receptor antagonists in vitro. Data sources: Published literature. Study selection: Recent experimental studies on anti-inflammatory effects of H1-receptor antagonists. Databases searched: Medline, Medscape. Period covered: 1990-2003. Search terms: second-, third-generation antihistamines; sedating, nonsedating antihistamines; in vitro anti-inflammatory activity; cetirizine; ebastine; loratadine… Expand
Alcaftadine, a new antihistamine with combined antagonist activity at histamine H1, H2, and H4 receptors
Correspondence: Robin L Thurmond Janssen Research and Development, LLC, 3210 Merryfield Row, San Diego, CA 92121, USA Email rthurmon@its.jnj.com Abstract: Current therapy for ocular allergy includesExpand
Characterization of Anti-Inflammatory Properties and Evidence for No Sedation Liability for the Novel Antihistamine SUN-1334H
TLDR
SUN-1334H and fexofenadine caused better inhibition at lower and middle dose levels than the other antihistamines and showed potent reduction of passive and active cutaneous anaphylactic reactions in skin allergy models and in central nervous system side effects models, which are suggestive of a high anti-inflammatory to sedation index. Expand
Antihistamine Activities of Iminodiacetamide Derivatives
Abstract − A series of N,N'- substituted iminodiacetamide derivatives was synthesized and evaluated their inhib-itory effects on the histamine-induced smooth muscle contraction in guinea-pig ileumExpand
Review of H 1 Antihistamines in the Treatment of Chronic Idiopathic Urticaria
Chronic idiopathic urticaria (CIU) can have a profound effect on patient quality of life (QOL). Ideally, any therapy used to treat CIU should be effective across a wide range of doses without causingExpand
Modern H1-antihistamines in asthma
TLDR
Further studies are needed to elucidate the role of modern H 1 -antihistamines in asthma management including their use in severe persistent or perennial asthma, and to evaluate their effects on lung function, tolerability at higher doses and long-term safety and efficacy. Expand
Neurophysiological and neurochemical basis of modern pruritus treatment
TLDR
Recent developments show that highlighting the basis of pruritus offers modern neurophysiological and neurochemical therapeutic models and the possibility to treat patients with refractory itching of different origin. Expand
Anti-Inflammatory Activity: Assessment of Benzo [6, 7] Cyclohepta [1, 2-b] Pyridine Derivatives
A variety of benzo [6,7] cyclohepta [1,2-b] pyridine derivatives have been evaluated for their in vitro anti-proliferative activity against four cancer cell lines such as HeLa (cervical), MIAPACAExpand
Roles of histamine and its receptors in allergic and inflammatory bowel diseases.
Mast cell has a long history of being recognized as an important mediator-secreting cell in allergic diseases, and has been discovered to be involved in IBD in last two decades. Histamine is a majorExpand
[Antipruritic efficacy of a high-dosage antihistamine therapy. Results of a retrospectively analysed case series].
TLDR
The results of this case series suggest a high antipruritic effect in chronic pruritus by administration of high-dosage, non-sedating antihistamines. Expand
Efficacy and Safety of Fexofenadine in the Treatment of Pruritus Associated with Eczema
TLDR
Fexofenadine administered 180 mg once daily in combination with topical prednicarbate treatment was effective and well tolerated in this study. Expand
...
1
2
3
...

References

SHOWING 1-10 OF 41 REFERENCES
Antiallergic effects of H1‐receptor antagonists
TLDR
Mizolastine, a new H1‐receptor antagonist, has been shown to have additional actions that should help reduce the allergic response, and is likely to have an effect on LT generation. Expand
Inhibition of eosinophil chemotaxis by a new antiallergic compound (cetirizine).
TLDR
It is confirmed that cetirizine, at therapeutical concentration, has a potent inhibitory action on eosinophil response to different chemoattractant mediators such as platelet-activating factor (PAF acether) and N-formyl methionyl leucyl phenyl alanyl in vitro. Expand
Desloratadine: A new, nonsedating, oral antihistamine.
TLDR
Clinical experience in over 2300 patients has shown that the adverse event profile of desloratadine is similar to that of placebo; deslor atadine has no clinically relevant effects on electrocardiographic parameters, does not impair wakefulness or Psychomotor performance, and does not exacerbate the psychomotor impairment associated with alcohol use. Expand
Antiinflammatory effects of oxatomide.
TLDR
The pharmacological activities of oxatomide are extended beyond H1 receptor antagonism and suggest that this drug influences a variety of biochemical events in human inflammatory cells, helping to explain its beneficial effect in various allergic and inflammatory disorders. Expand
Overview of allergic mechanisms. Ebastine has more than an antihistamine effect.
TLDR
When patients underwent nasal provocation tests with allergen, ebastine significantly increased the mean number of pollen grains required to induce an allergic response and the drug inhibited the release of granulocyte-macrophage colony-stimulating factor but had no effect on any other mediators measured. Expand
Inhibitory effect of cetirizine on cytokine-enhanced in vitro eosinophil survival.
  • J. Sedgwick, W. Busse
  • Medicine
  • Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology
  • 1997
TLDR
Although the in vitro concentration of cetirizine was required to be quite high, cetIRizine may affect in vivo airway inflammation through its inhibition of IL-5-dependent eosinophil survival. Expand
Therapeutic options in allergic disease: antihistamines as systemic antiallergic agents.
  • G. Marshall
  • Medicine
  • The Journal of allergy and clinical immunology
  • 2000
TLDR
Desloratadine, a new selective histamine H(1)-receptor antagonist with potent antihistaminic and anti-inflammatory activity, is introduced and its potential for treating the systemic aspects of allergic disease is discussed. Expand
Safety of Antihistamines in Children
TLDR
The availability of newer generation antihistamine compounds has clearly added to the clinical effectiveness and patient tolerance of a widely prescribed class of drugs and these advances have also been accompanied by improved safety profiles, particularly in the case of third generationAntihistamine overdose. Expand
Effect of fexofenadine on eosinophil-induced changes in epithelial permeability and cytokine release from nasal epithelial cells of patients with seasonal allergic rhinitis.
TLDR
It is suggested that fexofenadine may reduce nasal inflammation by modulating the release of proinflammatory mediators and adhesion molecules from HNEC. Expand
Effect of loratadine on human eosinophil function in vitro.
TLDR
It is suggested that loratadine has a direct inhibitory effect on eosinophil activation and may be beneficial in the therapy of allergic disorders with its anti-allergic properties. Expand
...
1
2
3
4
5
...